Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions

Journal of Virology

Volumn 70, Issue 1, 1996, Pages 341-351

  Freed, Eric O ^a   Martin, Malcolm A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 41; MATRIX PROTEIN; PLASMID DNA;

AMINO ACID SUBSTITUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LINE; DNA TRANSFECTION; GENE DELETION; GENE MAPPING; GENE MUTATION; HELA CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN TRANSPORT; REVERTANT; VIRION; VIRUS ENVELOPE; VIRUS INFECTIVITY;

AMINO ACID SEQUENCE; BASE SEQUENCE; BINDING SITES; CELL LINE; DNA, VIRAL; GENE PRODUCTS, ENV; GENE PRODUCTS, GAG; HELA CELLS; HIV ANTIGENS; HIV ENVELOPE PROTEIN GP160; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMAN; MOLECULAR SEQUENCE DATA; MUTAGENESIS; MUTATION; PROTEIN PRECURSORS; VIRAL ENVELOPE PROTEINS; VIRION;

EID: 0029655514     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.1.341-351.1996     Document Type: Article

References (70)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986 Production of acquired immunodeficiency syndrome-associaled retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Arthur, L., J. Bess, R. Sowder, R. Benveniste, D. Mann, J.-C. Chermann, and L. Henderson. 1992. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 258:1935-1938
3. Brody, B. A., S. S. Rhee, and E. Hunter. 1994. Postassembly cleavage of a retroviral glycoprotein cytoplasmic domain removes a necessary incorporation signal and activates fusion activity. J. Virol. 68:4620-4627.
4. Bukrinsky, M. I., S. Haggerty, M. P. Dempsey, N. Sharova, A. Adzhubei, L. Spitz, P. Lewis, D. Goldfarb, M. Emerman, and M. Stevenson. 1993. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature (London) 365:666-669.
5. Chakrabarti, L., M. Emerman, P. Tiollais, and P. Sonigo. 1989. The cytoplasmic domain of simian immunodeficiency virus transrnembrane protein modulates infectivity. J. Virol 63:4395-4403
6. Chazal, N., B. Gay, C. Carriere, J. Tournier, and P. Boulanger. 1995. Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and irons effects on the Gag precursor assembly pathway J. Virol 69:365-375.
7. Dorfman, T., F. Mammano, W. A. Haseltine, and H. G. Gottlinger. 1994. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 68:1689-1696.
8. Dubay, J. W., S. J. Roberts, B. H. Hahn, and E. Hunter. 1992. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic tail blocks virus infectivity. J. Virol. 66:6616-6625
9. Earl, P. L., S. Koenig, and B. Moss. 1991. Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein. analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses. J. Virol 65:31-41.
10. Felser, J. M., T. Klimkait, and J. Silver. 1989 A syncytia assay for human immunodeficiency virus type 1 (HIV-1) envelope protein and its use in studying HIV-1 mutations Virology 170:566-570.
11. Freed, E. O., G. Englund, and M. A. Martin. 1995. Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection J. Virol. 69:3949-3954.
12. Freed, E. O., and M. A. Martin. 1994. Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120 J Virol. 68:2503-2512
13. Freed, E. O., and M. A. Martin. 1995. Virion incorporation of envelope glycoprotcins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J Virol. 69:1984-1989.
14. Freed, E. O., and M. A. Martin. 1995. The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection. J. Biol. Chem. 270:23883-23886.
15. Freed, E. O., and M. A. Martin. Unpublished results.
16. Freed, E. O., D. J. Myers, and R. Risser. 1989. Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160 J. Virol. 63:4670-4-675.
17. Freed, E. O., D. J. Myers, and R. Risser. 1990. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc. Natl. Acad. Sci. USA 87:4650-4654
18. Freed, E. O., J. M. Orenstein, A. J. Buckler-White, and M. A. Martin. 1994. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J Virol. 68:5311-5320.
19. Gabuzda, D. H., A. Lever, E. Terwilliger, and J. Sodroski. 1992. Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 66:3306-3315.
20. Gamier, L., M. Ravallec, P. Blanchard, H. Chaabihi. J.-P. Bossy, G. Devauchelle, A. Jestin, and M. Cerutti. 1995 Incorporation of pseudorabies virus gD into human immunodeficiency virus type 1 Gag particles produced in baculovirus-infected cells. J. Virol 69:4060-4068
21. Gebhardt, A., J. V. Bosch, A. Ziemiecki, and R. R. Friis. 1984. Rous sarcoma virus p19 and gp35 can be chemically crosslinked to high molecular weight complexes. J Mol. Biol 174:297-317.
22. Gelderblom, H. R. 1991 Assembly and morphology of HIV: potential effect of structure on viral function. AIDS 5:617-638.
23. Granowitz, C., J. Colicelli, and S. P. Goff. 1991. Analysis of mutations in the envelope gene of Moloney murine leukemia virus, separation of infectivity from superinfection resistance. Virology 183:546-554.
24. Gray, K., and M. Roth. 1993. Mutational analysis of the envelope gene of Moloncy murine leukemia virus. J. Virol 67:3489-3496.
25. Heinzinger, N. K., M. I. Bukrinsky, S. A. Haggerty, A. M. Ragland, V. Kewalramani, M.-A. Lee, H. E. Gendelman, L. Ratner, M. Stevenson, and M. Emerman. 1994. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA 91:7311-7315.
26. Hirsch, V. M., P. Edmondson, M. Murphey-Corb, B. Arbeille, P. R. Johnson, and J. T. Mullins. 1989. SIV adaptation to human cells. Nature (London) 341:573-574.
27. Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol. Biol. 26:365-369.
28. Johnston, P. B., J. W. Dubay, and E. Hunter. 1993. Truncations of the simian immunodeficiency virus transmembrane protein confer expanded virus host range by removing a block to virus entry into cells. J. Virol. 67:3077-3086.
29. Kimpton, J., and M. Emerman. 1992 Detection of replication competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virol. 66:2232-2239.
30. Kodama, T., D. P. Wolley, Y. M. Naidu, H. W. Kestler III, M. D. Daniel, Y. Li, and R. C. Desrosiers. 1989. Significance of premature stop codons in env of simian immunodeficiency virus. J. Virol. 63:4709-4714.
31. Kowalski, M., J. Potz, L. Basiripour, T. Dorfman, W. C. Goh, E. Terwilliger, A. Dayton, C. Rosen, W. Haseltine, and J. Sodroski. 1987. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 237:1351-1355.
32. Kunkle, T. A., J. D. Roberts, and R. A. Zakour. 1987. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol 154:367-382.
33. Landau, N. R., K. A. Page, and D. R. Littman. 1991. Pseudotyping with human T-cell leukemia virus type 1 broadens the human immunodeficiency virus host range. J. Virol. 65:162-169
34. Lee, S.-J., W. Hu, A. G. Fisher, D. J. Looney, V. F. Kao, H. Mitsuya, L. Ratner, and F. Wong-Staal. 1989. Role of the carboxy-terminal portion of the HIV-1 transmembrane protein in viral transmission and cytopathogenicity. AIDS Res. Hum. Retroviruses 5:441-449.
35. Lodge, R., H. Göttlinger, D. Gabuzda, E. A. Cohen, and G. Lemay. 1994. The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells. J. Virol. 68:4857-4861.
36. Lusso, P., F. D. M. Veronese, B. Ensoli, G. Franchini, C. Jemma, S. E. DeRocco, V. S. Kalyanaraman, and R. C. Gallo. 1990 Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses. Science 247:848-852.
37. Maddon, P. J., A. G. Dalgleish, J. S. McDougal, P. R. Clapham. R. A. Weiss, and R. Axel. 1986. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333-348.
38. Mammano, F., E. Kondo, J. Sodroski, A. Bukovsky, and H. G. Göttlinger. 1995. Rescue of human immunodeficiency virus Type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. J. Virol. 69:3824-3830.
39. Massiah, M. A., M. R. Starich, C. Paschall, M. F. Summers, A. M. Christensen, and W. I. Sundquist. 1994. Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein. J. Mol Biol. 244:198-223.
40. Matthews, S., P. Barlow, J. Boyd, G. Barton, R. Russel, H. Mills, M. Cunningham, N. Meyers, N. Burns, N. Clark, S. Kingsman, A. Kingsman, and I. Campbell. 1994. Structural similarity between the p17 matrix protein of HIV-1 and interferon-γ. Nature (London) 370:666-668.
41. Mervis, R. J., N. Ahmad, E. P. Lillehoj, M. G. Raum, F. H. R. Salazar, H. W. Chan, and S. Venkatesan. 1988. The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors. J. Virol. 62:3993-4002.
42. Mulligan, M. J., G. V. Yamshchikov, G. D. Ritter, Jr., F. Gao, M. J. Jin, C. D. Nail, C. P. Spies, B. H. Hahn, and R. W. Compans. 1992. Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cells. J Virol 66:3971-3975.
43. Myers, G., S. Wain-Hobson, B. Korber, R. F. Smith, and G. N. Pavlakis (ed.). 1993. Human retroviruses and AIDS. A compilation and analysis of nucleic acid and ammo acid sequences. Los Alamos National Laboratory, Los Alamos. N.Mex.
44. Owens. R. J., J. W. Dubay, E. Hunter, and R. W. Compans. 1991 Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells. Proc. Natl. Acad. Sci. USA 88:3987-3991
45. Paredes, A. M., D. T. Brown, R. Rothnagel, W. Chiu, R. J. Schoepp, R. E. Johnston, and B. V. V. Prasad. 1993. Three-dimensional structure of a membrane-containing virus. Proc. Natl. Acad. Sci. USA 90:9095-9099.
46. Perez, L. G., G. L. Davis, and E. Hunter. 1987 Mutants of the Rous sarcoma virus envelope glycoprotein that lack the transmembrane anchor and cytoplasmic domains: analysis of intracellular transport and assembly into virions. J Virol 61:2981-2988.
47. Rein, A., J. Mirro, J. G. Haynes, S. M. Ernst, and K. Nagashima. 1994. Function of the cytoplasmic domain of a retroviral transmembrane protein p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J. Virol. 68:1773-1781.
48. Rhee, S. S., and E. Hunter. 1990. A single amino acid substitution within the matrix protein of a type D retrovirus converts its morphogenesis to that of a type C retrovirus. Cell 63:77-06.
49. Ritter, G. D., Jr., M. J. Mulligan, S. L. Lydy, and R. W. Compans. 1993. Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracycoplasmic domain. Virology 197:255-264.
50. Ross, E. K., A. J. Buckler-White, A. B. Rabson. G. Englund, and M. A. Martin. 1991. Contribution of NF-κB and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types J Virol. 65:4350-4358.
51. Simpson, D. A., and R. A. Lamb. 1992. Alterations to influenza virus hemagglutinin cytoplasmic tail modulate virus infectiviry. J. Virol. 66:790-803.
52. Spearman, P., J.-J. Wang, N. V. Heyden, and L. Ratner. 1994. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J. Virol. 68:3232-3242
53. Spector, D. H., E. Wade, D. A. Wright, V. Koval, C. Clark, D. Jaquish, and S. A. Spector. 1990 Human immunodeficiency virus pseudotypes with expanded cellular and species tropism. J. Virol. 64:2298-2308.
54. Spies, C. P., and R. W. Compans. 1994. Effects of cytoplasmic domain length on cell surface expression and syncytium-forming capacity of the simian immunodeficiency virus envelope glycoprotein. Virology 203:8-19.
55. Spies, C. P., G. D. Ritter, Jr., M. J. Mulligan, and R. W. Compans. 1994 Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain. J. Virol. 68:585-591.
56. Suomalainen, M., P. Liljestrom, and H. Garoff. 1992. Spike protein-nucleocapsid interactions drive the budding of alphaviruses. J Virol. 66:4737-4747
57. Vaux, J. T., A. Helenius, and I. Mellman. 1988. Spike-nucleocapsid interaction in Semliki Forest virus reconstructed using network antibodies. Nature (London) 336:36-42
58. Venable, R. M., R. W. Pastor, B. R. Brooks, and F. W. Carson. 1989. Theoretically determined three-dimensional structures for amphipathic segments of the HIV-1 gp41 envelope protein. AIDS Res. Hum. Retroviruses 5:7-22.
59. von Schwedler, U., R. S. Kornbluth, and D. Trono. 1994. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes Proc Natl. Acad. Sci. USA 91:6992-6996
60. Wang, C.-T., and E. Barklis. 1993. Assembly, processing, and infectivity of human immunodeficiency virus type 1 Gag mutants. J. Virol. 67:4264-1273
61. Wilk, T., T. Pfeiffer, and V. Bosch. 1992. Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product. Virology 189:167-177.
62. Willey, R. L., J. S. Bonifacino, B. J. Potts, M. A. Martin, and R. D. Klausner. 1988 Biosynthesis, cleavage and degradation of the human immunodeficiency virus type 1 envelope glycoprotein gp160. Proc. Natl. Acad Sci. USA 85:9580-9584.
63. Wills, J. W., and R. C. Craven. 1991. Form, function, and use of retroviral Gag proteins. AIDS 5:639-654.
64. Wilson, C., M. S. Reitz, H. Okayama, and M. V. Eiden. 1989. Formation of infectious hybrid virions with gibbon ape leukemia virus and human T-cell leukemia virus retroviral envelope glycoproteins and the gag and pol proteins of Moloney murnie leukemia virus. J. Virol. 63:2374-2378.
65. Yu, X., Q.-C. Yu, T.-H. Lee, and M. Essex. 1992. The C terminus of human immunodeficiency virus type 1 matrix protein is involved in early steps of the virus life cycle. J. Virol. 66:5667-5670.
66. Yu, X., X. Yuan, Z. Matsuda, T.-H. Lee, and M. Essex. 1992. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J. Virol. 66:4966-1971.
67. Yu, X., X. Yuan, M. F. McLane, T.-H. Lee, and M. Essex. 1993. Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions. J. Virol. 67:213-221.
68. Yuan, Y., X. Yu. T.-H. Lee, and M. Essex. 1993. Mutations in the N-termmal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor. J. Virol. 67:6387-6394.
69. Zhou, W., L. J. Parent, J. W. Wills, and M. D. Resh. 1994. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phosphohpids. J. Virol. 68:2556-2569
70. Zingler, K., and D. R. Littman. 1993. Truncation ot the cyloplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases Env incorporation into virus particles and fusogemcity and infectivity. J. Virol. 67:2824-2831